Modulation of estrobolome may help lower breast cancer risk

[News]

Investigating disparities in the composition of the estrobolome, the gut bacterial genes capable of metabolizing estrogens in both healthy individuals and in women diagnosed with estrogen-driven breast cancer may lead to the development of microbiome-based biomarkers that could help mitigate the risk of certain cancers, according to a review paper published April 22 in the JNCI: Journal of the National Cancer Institute.

More... (http://www.news-medical.net/news/20160425/Modulation-of-estrobolome-may-help-lower-breast-cancer-risk.aspx)